Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
NMEz-2881529 by ZYUS Life Sciences for Neuropathic Pain (Neuralgia): Likelihood of Approval
NMEz-2881529 is under clinical development by ZYUS Life Sciences and currently in Phase I for Neuropathic Pain (Neuralgia). According to...